Back

SGLT2 inhibitors for the treatment of heart failure.

31 August 2020 (11:05 - 11:15)
Organised by:
Congress Presentation Part of: Pharmacological Treatment of Chronic Heart Failure Treatment ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
Old drugs in the modern era: ACEI/ARB, MRAs+digoxin.
Professor M. Pfeffer (Boston, US)
Slides Video
Presentation thumbnail
New drugs on the horizon: sGC stimulators, myosin activators.
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Sacubitril/valsartan: opportunities and challenges.
Professor J. McMurray (Glasgow, GB)
Slides Video

Access the full session

Session thumbnail
Pharmacological Treatment of Chronic Heart Failure

The Event

Event poster

ESC Congress 2020

31 August 2020 11:05 CET
You may be interested in
thumbnail
Webinar
SGLT2 inhibitors across the left ventricular function spectrum
24 September 2024
thumbnail
Congress Presentation
Characterization of myocardial sodium-glucose cotransporter 1 expression in humans with heart failure and reduced ejection fraction
29 August 2020
thumbnail
Congress Presentation
The use of SGLT-2 inhibitors and hemoconcentration in patients with heart failure
11 May 2024
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources